Source: Siyu MedTech; Editor: Xiong Xiaoke
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.
GE Healthcare (NASDAQ: GEHC) announced today a collaboration with Biofourmis to enable safe, effective, and convenient care for patients at home.
Biofourmis, founded in 2015 and currently headquartered in Boston, USA, is a digital therapeutics startup primarilyBy integrating AI software and hardware facilities to monitor patients and predict diseases, providing more convenient clinical support services for home care and digital diagnosis and treatment.。
Biovitals Index Home Care, RhythmAnalytical Arrhythmia, Patient Companion App User Companion Software, and Clinician Dashboard Clinical Dashboard are all product services developed by Biofourmis.
In April 2022, Biofourmis secured $300 million in Series D funding, bringing the company's valuation to over $1 billion.Join the ranks of digital therapeutics unicornsAfter multiple rounds of financing, the company's financing scale reached 463.6 million US dollars in 2022, with a valuation of 1.3 billion.
The two companies join hands to ensure care for patients outside the hospital. To achieve this, both parties have utilized comprehensive expertise in innovative home care solutions.They indicated that the hospital system is facing increased care costs due to a shortage of medical staff, reduced bed capacity, and rising readmission rates, while home care is...While promoting patient recovery and ensuring safety, it can reduce the risk of falls and hospital infection rates.。GE Healthcare and BioFourmis Aim to Help More Patients Return Home Sooner. They aspire to offer care solutions beyond medical facilities, enabling patient recovery through remote management. According to reports, Biofourmis' AI-guided algorithm, FDA-approved, helps deliver personalized care.“Biofourmis' successful home care solutions will be integrated with GE Healthcare's current inpatient monitoring."To support patients in transitioning from hospital to home care," said Ashutosh Banerjee, General Manager of GE Healthcare's Cardiology Solutions and Remote Patient Monitoring division. "Combined with the outstanding capabilities of both parties,Will help revolutionize the way patient care is delivered and address the challenges facing healthcare systems.”
# More Information on the Collaboration between GE Healthcare and Biofourmis
Biofourmis' home-based solution helps peopleCoordinating Online and Offline Care Through a Digital PlatformThis is made possible by its AI-guided algorithms, clinical-grade wearable devices, home service orchestration technology, and nursing services.In addition, the company's solutions provideDynamic Nursing Pathway with Questionnaire Branching Logic, as well as strong clinical performance.GE Healthcare's FlexAcuity monitoring solution is equipped with virtual care solutions, including the new "Virtual Clinical Command Center" (Mural) for use in the ICU, the Command Center, and the Digital Central Monitoring Unit (Digital CMU). These products can meet the rapidly changing needs of hospital patients. GE Healthcare believes that, with the support of Biofourmis' home-based solutions, care can be extended beyond the hospital.
Biofourmis Care Solution was launched in 2022.A first-of-its-kind technology-enabled care treatment service that provides high-quality remote treatment for patients with chronic diseases.。"Our collaboration will enable health systems and hospitals to harness the power of technology and data," said Ross Armstrong, General Manager of the solution.Develop Patient-Centered Solutions Throughout the Entire Care Process, regardless of the location of care."In addition, GE Healthcare will begin promoting the Biofourmis solution to U.S. customers in the first quarter of 2024.
Global MedTech TOP100: 2023 Global MedTech TOP100
2023 Global MedTech Industry Contribution Award
2023 Global Medical Technology Innovation Award
2023 Global MedTech Pioneer Award
2023 Global Innovative Medical Device Award
Global Leading Medical Device Companies | Dynamic CollectionChina Medical Device Listed Companies | Dynamic CollectionEditor-in-Chief | Zhao Qing Reviewed by | Yi He
